Right Ventricular Diastolic Function Predicts Adverse Outcomes After Pulmonary Valve Replacement in Patients With

Takashi Kido1, Yosuke Kugo1, Motoki Komori1

  • 1Department of Cardiovascular Surgery, The University of Osaka Graduate School of Medicine Osaka Japan.

Circulation Reports
|August 11, 2026
PubMed

Insights

Pulmonary valve replacement (PVR) timing in repaired tetralogy of Fallot (TOF) is crucial. Right ventricular diastolic dysfunction significantly impacts outcomes, and age over 35 is a risk factor only in these patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Congenital Heart Disease

Background:

  • Pulmonary valve replacement (PVR) timing in repaired tetralogy of Fallot (TOF) is debated.
  • Right ventricular (RV) diastolic dysfunction's role in post-PVR outcomes needs clarification.
  • Investigating age as a universal risk factor for adverse outcomes after PVR.

Purpose of the Study:

  • To examine the influence of RV diastolic dysfunction on post-PVR outcomes in repaired TOF patients.
  • To determine if age ≥35 years at PVR universally predicts adverse outcomes or is subgroup-specific.

Main Methods:

  • Retrospective review of 81 patients undergoing PVR for repaired TOF (2002-2022).
  • Defined adverse outcomes: arrhythmia treatment or heart failure hospitalization.
  • Defined RV diastolic dysfunction: RV end-diastolic pressure ≥12 mmHg and/or RA volume index ≥83 mL/m².
  • Used Cox regression and subgroup analyses.

Main Results:

  • Adverse outcomes occurred in 30% of patients.
  • Right atrial (RA) volume index was the sole independent predictor of adverse outcomes.
  • Age ≥35 years at PVR was linked to adverse events only in patients with RV diastolic dysfunction.

Conclusions:

  • RV diastolic dysfunction is significantly associated with adverse post-PVR clinical outcomes.
  • Advanced age (≥35 years) at PVR is a risk factor only in patients with RV diastolic dysfunction, not universally.
  • Patient-specific factors like RV diastolic dysfunction are critical for PVR timing decisions.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...